RO4995819
Sponsors
Hoffmann-La Roche, Stanford University
Conditions
DepressionHealthy VolunteerMajor Depressive Disorder
Phase 1
A Study of RO4995819 in Combination With Citalopram in Healthy Volunteers
CompletedNCT01367756
Start: 2011-05-31End: 2011-09-30Updated: 2016-11-02
A Study on The Effect of Multiple Doses of Activated Charcoal on The Pharmacokinetics of a Single Dose of RO4995819
CompletedNCT01409369
Start: 2011-08-31End: 2012-02-29Updated: 2016-11-02
A Study of RO4995819 in Healthy Elderly Volunteers
CompletedNCT01457664
Start: 2011-07-31End: 2011-12-31Updated: 2016-11-02
A Study of RO4995819 to Assess Bioavailability and Safety in Healthy Volunteers
CompletedNCT01901159
Start: 2013-06-30End: 2013-11-30Updated: 2016-11-02
Phase 2
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
CompletedNCT01457677
Start: 2011-12-31End: 2014-06-30Updated: 2016-11-02
Investigate Efficacy & Safety of RO4995819 vs. Placebo as Adjunct Tx in Patients w/Major Depressive Disorder
WithdrawnNCT01733654
Start: 2012-09-30End: 2014-05-31Updated: 2019-10-04